Cargando…
The Effects of Immunosuppressive Drugs on the Characteristics and Functional Properties of Bone Marrow-Derived Stem Cells Isolated from Patients with Diabetes Mellitus and Peripheral Arterial Disease
Background: Diabetic patients (DPs) with foot ulcers can receive autologous cell therapy (ACT) as a last therapeutic option. Even DPs who have undergone organ transplantation and are using immunosuppressive (IS) drugs can be treated by ACT. The aim of our study was to analyze the effects of IS drugs...
Autores principales: | Husakova, Jitka, Echalar, Barbora, Kossl, Jan, Palacka, Katerina, Fejfarova, Vladimira, Dubsky, Michal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377428/ https://www.ncbi.nlm.nih.gov/pubmed/37509511 http://dx.doi.org/10.3390/biomedicines11071872 |
Ejemplares similares
-
Cell Therapy of Severe Ischemia in People with Diabetic Foot Ulcers—Do We Have Enough Evidence?
por: Dubský, Michal, et al.
Publicado: (2023) -
Stimulation TcPO2 Testing Improves Diagnosis of Peripheral Arterial Disease in Patients With Diabetic Foot
por: Fejfarová, Vladimíra, et al.
Publicado: (2021) -
Microdialysis as a tool for antibiotic assessment in patients with diabetic foot: a review
por: Fejfarová, Vladimíra, et al.
Publicado: (2023) -
Comparison of the impact of autologous cell therapy and conservative standard treatment on tissue oxygen supply and course of the diabetic foot in patients with chronic limb-threatening ischemia: A randomized controlled trial
por: Dubský, Michal, et al.
Publicado: (2022) -
Effects of a 12-Week Interventional Exercise Programme on Muscle Strength, Mobility and Fitness in Patients With Diabetic Foot in Remission: Results From BIONEDIAN Randomised Controlled Trial
por: Vrátná, Eliška, et al.
Publicado: (2022)